Adamed Pharma is an international pharmaceutical and biotechnology company founded on the Polish science advances and a patent portfolio. For over 35 years the company has been providing patients with medicinal products of the highest quality in many therapeutic areas, such as: cardiology, psychiatry, pulmonology, gynecology and treatment of the urinary tract infections. Currently, it manufactures over 500 products offered to the patients in dozens of countries around the world. The company employs 2,400 people globally.

Adamed Pharma is famous for carrying out innovative R&D works. It establishes scientific and industrial consortia with leading universities and scientific institutes in the homeland and abroad. The company’s intellectual property is protected by more than 200 patents all over the world.

Since 2017, Adamed Pharma holds the controlling stake of one of the fastest growing Vietnam’s pharmaceutical companies, Davipharm. It has been the biggest direct private Polish investment in Vietnam. The company invests in upgrading the quality standards (certified with EU-GMP in 2021), and technology transfers.

Adamed’s investment in Vietnam is also geared towards human development and societal improvement. As a socially responsible business, the company funds educational program Adamed SmartUP supporting local community of Viet Nam-Ba Lan School in Hanoi, Internship Program with the Binh Duong Medical College and HCMC University of Medicine and Pharmacy, and Non-Communicable Diseases Prevention and Early Detection Program „Chăm Sóc Sức Khỏe Việt” in partnership with the Vietnamese Ministry of Health.

For Adamed, Vietnam is a platform for further dynamic expansion in the Asia-Pacific region.